CDKN1A and neoplasm: To determine the relevance of p21Cip1 to cyclin D1 localisation and proliferation, p21Cip1 immunoreactivity was assessed in a subset of patient tumours (n=16) and the three metastatic tumours wherein cyclin D1 and Ki-67 status had been determined.